Stockreport

How FDA Breakthrough Status For TSHA-102 At Taysha Gene Therapies (TSHA) Has Changed Its Investment Story [Yahoo! Finance]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF progress on TSHA-102 for Rett syndrome and receiving FDA Breakthrough Therapy designation. The company's preparation for potential commercialization, including the hir [Read more]